Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

作者: Li Zhang , Kenzie D. MacIsaac , Ting Zhou , Pei-Yu Huang , Chunlin Xin

DOI: 10.1158/1541-7786.MCR-17-0134

关键词:

摘要: Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated cancer characterized by a poor prognosis and high level of lymphocyte infiltrate. Genetic hallmarks NPC are not completely known but include deletion the p16 (CDKN2A) locus mutations in NF-κB pathway components, with relatively low total mutational load. To better understand genetic landscape, integrated genomic analysis was performed using large clinical cohort treatment-naive tumor specimens. This generally concordant previous studies; however, three subtypes were identified differences immune cell gene expression, prognosis, morphology, characteristics. A expression signature proliferation poorly prognostic either higher mutation load or specific EBV patterns subtype-specific manner. Finally, levels stromal tumor-infiltrating lymphocytes good lower WNT TGFβ activation signature.Implications: study represents first mutation, copy number, data suggests how genetics infection influence microenvironment this disease. These insights should be considered for guiding immunotherapy treatment strategies Mol Cancer Res; 15(12); 1722-32. ©2017 AACR.

参考文章(48)
Stefani Spranger, Riyue Bao, Thomas F. Gajewski, Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity Nature. ,vol. 523, pp. 231- 235 ,(2015) , 10.1038/NATURE14404
Lawrence S. Young, Christopher W. Dawson, Epstein-Barr virus and nasopharyngeal carcinoma. Chinese Journal of Cancer. ,vol. 33, pp. 581- 590 ,(2014) , 10.5732/CJC.014.10197
Gongxian Liao, Minying Zhang, Edward W. Harhaj, Shao-Cong Sun, Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation Journal of Biological Chemistry. ,vol. 279, pp. 26243- 26250 ,(2004) , 10.1074/JBC.M403286200
Brigette Ma, Edwin P. Hui, Ann King, K. F. To, Frankie Mo, Sing F. Leung, Michael Kam, Y. M. Dennis Lo, Benny Zee, Tony Mok, Anil Ahuja, Anthony T. C. Chan, A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy. Cancer Chemotherapy and Pharmacology. ,vol. 62, pp. 59- 64 ,(2008) , 10.1007/S00280-007-0575-8
Claire Gourzones, Clément Barjon, Pierre Busson, Host-tumor interactions in nasopharyngeal carcinomas. Seminars in Cancer Biology. ,vol. 22, pp. 127- 136 ,(2012) , 10.1016/J.SEMCANCER.2012.01.002
Anne WM Lee, Wai Tong Ng, Lucy LK Chan, Wai Man Hung, Connie CC Chan, Henry CK Sze, Oscar SH Chan, Amy TY Chang, Rebecca MW Yeung, None, Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era. Radiotherapy and Oncology. ,vol. 110, pp. 377- 384 ,(2014) , 10.1016/J.RADONC.2014.02.003
A. K. F. Lo, K. F. To, K. W. Lo, R. W. M. Lung, J. W. Y. Hui, G. Liao, S. D. Hayward, Modulation of LMP1 protein expression by EBV-encoded microRNAs Proceedings of the National Academy of Sciences. ,vol. 104, pp. 16164- 16169 ,(2007) , 10.1073/PNAS.0702896104
A. Liberzon, A. Subramanian, R. Pinchback, H. Thorvaldsdottir, P. Tamayo, J. P. Mesirov, Molecular signatures database (MSigDB) 3.0 Bioinformatics. ,vol. 27, pp. 1739- 1740 ,(2011) , 10.1093/BIOINFORMATICS/BTR260
Su-Mei Cao, Malcolm J. Simons, Chao-Nan Qian, The prevalence and prevention of nasopharyngeal carcinoma in China Chinese Journal of Cancer. ,vol. 30, pp. 114- 119 ,(2011) , 10.5732/CJC.010.10377
Mei-Chi Hsu, Jenn-Ren Hsiao, Kung-Chao Chang, Yuan-Hua Wu, Ih-Jen Su, Ying-Tai Jin, Yao Chang, Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma Modern Pathology. ,vol. 23, pp. 1393- 1403 ,(2010) , 10.1038/MODPATHOL.2010.130